Registro:

Referencias:

• Levine, M.J., Reddy, M.S., Tabak, L.A., Structural aspects of salivary glycoproteins (1987) J. Dent. Res., 66, pp. 436-441
• Brockhausen, I., Schachter, H., Stanley, P., O-GalNAc Glycans (2009) Essentials of Glycobiology, pp. 115-127. , A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart & M.E. Etzler, Eds.: Cold Spring Harbor Cold Spring Harbor Laboratory Press
• Stanley, P., Schachter, H., Taniguchi, N., N-Glycans (2009) Essentials of Glycobiology, pp. 101-114. , A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart & M.E. Etzler, Eds.:. Cold Spring Harbor Cold Spring Harbor Laboratory Press
• Nothaft, H., Szymanski, C.M., Protein glycosylation in bacteria: sweeter than ever (2010) Nat. Rev. Microbiol., 8, pp. 765-778
• Theodore, M., Morava, E., Congenital disorders of glycosylation: sweet news (2011) Curr. Opin. Pediatr., 23, pp. 581-587
• Van Geet, C., Jaeken, J., Freson, K., Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications (2001) J. Inherit. Metab Dis., 24, pp. 477-492
• Wang, Y., Tan, J., Sutton-Smith, M., Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis (2001) Glycobiology, 11, pp. 1051-1070
• Ohtsubo, K., Marth, J.D., Glycosylation in cellular mechanisms of health and disease (2006) Cell, 126, pp. 855-866
• Takahashi, M., Kuroki, Y., Ohtsubo, K., Taniguchi, N., Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins (2009) Carbohydr. Res., 344, pp. 1387-1390
• Oberg, F., Sjohamn, J., Fischer, G., Glycosylation increases the thermostability of human aquaporin 10 protein (2011) J. Biol. Chem., 286, pp. 31915-31923
• Garner, O.B., Baum, L.G., Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling (2008) Biochem. Soc. Trans., 36, pp. 1472-1477
• Boscher, C., Dennis, J.W., Nabi, I.R., Glycosylation, galectins and cellular signaling (2011) Curr. Opin. Cell. Biol., 23, pp. 383-392
• Li, Y., Li, H., Dimasi, N., Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II (2001) Immunity, 14, pp. 93-104
• Dai, S., Murphy, G.A., Crawford, F., Crystal structure of HLA-DP2 and implications for chronic beryllium disease (2010) Proc. Natl. Acad. Sci. USA, 107, pp. 7425-7430
• Harrison, R.L., Jarvis, D.L., Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins (2006) Adv. Virus Res., 68, pp. 159-191
• Blixt, O., Head, S., Mondala, T., Printed covalent glycan array for ligand profiling of diverse glycan binding proteins (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 17033-17038
• Comelli, E.M., Head, S.R., Gilmartin, T., A focused microarray approach to functional glycomics: transcriptional regulation of the glycome (2006) Glycobiology, 16, pp. 117-131
• Demetriou, M., Granovsky, M., Quaggin, S., Dennis, J.W., Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation (2001) Nature, 409, pp. 733-739
• Ryan, S.O., Bonomo, J.A., Zhao, F., Cobb, B.A., MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation (2011) J. Exp. Med., 208, pp. 1041-1053
• Amith, S.R., Jayanth, P., Franchuk, S., Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase (2009) Glycoconj. J., 26, pp. 1197-1212
• Amith, S.R., Jayanth, P., Franchuk, S., Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling (2010) Cell Signal., 22, pp. 314-324
• van Kooyk, Y., Geijtenbeek, T.B., DC-SIGN: escape mechanism for pathogens (2003) Nat. Rev. Immunol., 3, pp. 697-709
• Andersson, K.B., Draves, K.E., Magaletti, D.M., Characterization of the expression and gene promoter of CD22 in murine B cells (1996) Eur. J. Immunol., 26, pp. 3170-3178
• O'Reilly, M.K., Tian, H., Paulson, J.C., CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells (2011) J. Immunol., 186, pp. 1554-1563
• Liu, F.T., Rabinovich, G.A., Galectins: regulators of acute and chronic inflammation (2010) Ann. N. Y. Acad. Sci., 1183, pp. 158-182
• Anthony, R.M., Kobayashi, T., Wermeling, F., Ravetch, J.V., Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway (2011) Nature, 475, pp. 110-113
• Kaneko, Y., Nimmerjahn, F., Ravetch, J.V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation (2006) Science, 313, pp. 670-673
• Matsushita, M., Ficolins: complement-activating lectins involved in innate immunity (2010) J. Innate. Immun., 2, pp. 24-32
• Stanley, P., Okajima, T., Roles of glycosylation in Notch signaling (2010) Curr. Top. Dev. Biol., 92, pp. 131-164
• Lowe, J.B., Glycan-dependent leukocyte adhesion and recruitment in inflammation (2003) Curr. Opin. Cell Biol., 15, pp. 531-538
• Mitoma, J., Bao, X., Petryanik, B., Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment (2007) Nat. Immunol., 8, pp. 409-418
• Pashov, A., Garimalla, S., Monzavi-Karbassi, B., Kieber-Emmons, T., Carbohydrate targets in HIV vaccine research: lessons from failures (2009) Immunotherapy, 1, pp. 777-794
• Krinos, C.M., Coyne, M.J., Weinacht, K.G., Extensive surface diversity of a commensal microorganism by multiple DNA inversions (2001) Nature, 414, pp. 555-558
• Carlin, A.F., Lewis, A.L., Varki, A., Nizet, V., Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes (2007) J. Bacteriol., 189, pp. 1231-1237
• van Kooyk, Y., Rabinovich, G.A., Protein-glycan interactions in the control of innate and adaptive immune responses (2008) Nat. Immunol., 9, pp. 593-601
• Drickamer, K., C-type lectin-like domains (1999) Curr. Opin. Struct. Biol., 9, pp. 585-590
• Figdor, C.G., van Kooyk, Y., Adema, G.J., C-type lectin receptors on dendritic cells and Langerhans cells (2002) Nat. Rev. Immunol., 2, pp. 77-84
• Kawasaki, T., Li, M., Kozutsumi, Y., Yamashina, I., Isolation and characterization of a receptor lectin specific for galactose/N-acetylgalactosamine from macrophages (1986) Carbohydr. Res., 151, pp. 197-206
• van Vliet, S.J., Saeland, E., van Kooyk, Y., Sweet preferences of MGL:carbohydrate specificity and function (2008) Trends Immunol., 29, pp. 83-90
• Zelensky, A.N., Gready, J.E., The C-type lectin-like domain superfamily (2005) FEBS J., 272, pp. 6179-6217
• Engering, A., Geijtenbeek, T.B., van Vliet, S.J., The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells (2002) J. Immunol., 168, pp. 2118-2126
• Unger, W.W.J., van Kooyk, Y., Dressed for success; C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells (2011) Curr. Opin Immunol., 23, pp. 131-137
• Birkholz, K., Schwenkert, M., Kellner, C., Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation (2010) Blood, 116, pp. 2277-2285
• Singh, S.K., Stephani, J., Schaefer, M., Targeting of glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation (2009) Mol. Immunol., 47, pp. 164-174
• Idoyaga, J., Cheong, C., Suda, K., Langerin/CD207 receptor on dendritic cells mediates efficiënt antigen presentation of non MHC I and II products in vivo (2008) J. Immunol., 180, pp. 3647-3650
• Bozzacco, L., Trumpfheller, C., Siegal, F.P., DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 1289-1294
• Sancho, D., Mourao-Sa, D., Joffre, O.P., Tumor therapy in mice via antigen targeting to a novel DC restricted C-type lectin (2008) J. Clin. Invest., 118, pp. 2098-2110
• Osorio, F., Reis e Sousa, C., Myeloid C-type lectin receptors in pathogen recognition and host defense (2011) Immunity, 34, pp. 651-664
• Park, C.G., Takahara, K., Umemoto, E., Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN (2001) Int. Immunol., 13, pp. 1283-1290
• Singh, S.K., Streng-Ouwehand, I., Litjens, M., Characterization of murine MGL 1 and MGL 2 C-type lectins: Distinct glycan specificities and tumor binding properties (2009) Mol. immunol., 46, pp. 1240-1249
• Denda-Nagai, K., Aida, S., Saba, K., Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells (2010) J. Biol. Chem., 285, pp. 19193-19204
• Brown, G.D., Dectin-1: a signaling non-TLR pattern-recognition receptor (2006) Nat. Rev. Immunol., 6, pp. 33-43
• Van Die, I., Cummings, R.D., Glycan mimmickry by parasitic helminths: a strategy for modulating the host immune response? (2010) Glycobiology, 20, pp. 2-12
• Gow, N.A.R., van de Veerdonk, F.L., Brown, A.J.P., Netea, M.G., Candida albicans morphogenesis and host defense: discriminating invasion from colonization (2012) Nat. Rev. Microbiol., 10, pp. 112-122
• Aarnoudse, C.A., Bax, M., Sánchez-Hernández, M., Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells (2008) Int. J. Cancer, 122, pp. 839-846
• Gringhuis, S.I., van Dunnen, J., Litjens, M., C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB (2007) Immunity, 26, pp. 605-616
• Gringhuis, S.I., den Dunnen, J., Litjens, M., Carbohydrate-specific signalling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori (2009) Nat. Immunol., 10, pp. 1081-1088
• Geijtenbeek, T.B., Gringhuis, S.I., Signalling through C-type lectin receptors: shaping immune responses (2009) Nat. Rev. Immunol., 9, pp. 465-479
• Geijtenbeek, T.B.H., van Vliet, S.J., Engering, A., Self- and non-self recognition by C-type lectins on dendritic cells (2003) Ann. Rev. Immunol., 22, pp. 33-54
• Dam, T.K., Brewer, C.F., Lectins as pattern recognition molecules: the effects of epitope density in innate immunity (2010) Glycobiology, 20, pp. 270-279
• van Gisbergen, K.P.J.M., Aarnoudse, C.A., Meijer, G.A., Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (2005) Cancer Res., 65, pp. 5935-5943
• Saeland, E., van Vliet, S.J., Bäckström, M., The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma (2007) Cancer Immunol. Immunother., 56, pp. 1225-1236
• Geijtenbeek, T.B.H., Kwon, D.S., Torensma, R., DC-SIGN, a dendritic cell specific HIV-1 binding protein that enhances trans-infection of T cells (2000) Cell, 100, pp. 587-597
• de Witte, L., Nabatov, A., Prion, M., Langerin is a natural barrier to HIV-1 transmission by Langerhans cells (2007) Nat. Med., 13, pp. 367-371
• Lambert, A.A., Gilbert, C., Richard, M., The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways (2008) Blood, 112, pp. 1299-1307
• Garcia-Vallejo, J.J., van Kooyk, Y., Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostatis (2009) Immunol. Rev., 230, pp. 22-37
• van Gisbergen, K.P.J.M., Sanchez-Hernandez, M., Geijtenbeek, T.B., van Kooyk, Y., Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN (2005) J. Exp. Med., 201, pp. 1281-1292
• van Vliet, S.J., Gringhuis, S.I., Geijtenbeek, T.B., van Kooyk, Y., Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45 (2006) Nat. Immunol., 24, pp. 1200-1208
• Crocker, P.R., Paulson, J.C., Varki, A., Siglecs and their roles in the immune system (2007) Nat. Rev. Immunol., 7, pp. 255-266
• O'Reilly, M.K., Paulson, J.C., Siglecs as targets for therapy in immune-cell-mediated disease (2009) Trends Pharmacol. Sci., 30, pp. 240-248
• Angata, T., Varki, A., Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective (2002) Chem. Rev., 102, pp. 439-469
• Avril, T., Wagner, E.R., Willison, H.J., Crocker, P.R., Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides (2006) Infect. Immun., 74, pp. 4133-4141
• Paul, S.P., Taylor, L.S., Stansbury, E.K., McVicar, D.W., Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2 (2000) Blood, 96, pp. 483-490
• Liu, Y., Chen, G.Y., Zheng, P., CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns (2009) Trends Immunol., 30, pp. 557-561
• Blasius, A.L., Colonna, M., Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H (2006) Trends Immunol., 27, pp. 255-260
• Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation (2009) Nat. Rev. Immunol., 9, pp. 338-352
• Di Lella, S., Sundblad, V., Cerliani, J.P., When galectins recognize glycans: from biochemistry to physiology and back again (2011) Biochemistry, 50, pp. 7842-7857
• Sato, S., St-Pierre, C., Bhaumik, P., Nieminen, J., Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs) (2009) Immunol. Rev., 230, pp. 172-187
• Brewer, C.F., Miceli, M.C., Baum, L.G., Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions (2002) Curr. Opin. Struct. Biol., 12, pp. 616-623
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8, pp. 825-834
• Zhu, C., Anderson, A.C., Schubart, A., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) Nat. Immunol., 6, pp. 1245-1252
• Cooper, D., Ilarregui, J.M., Pesoa, S.A., Multiple functional targets of the immunoregulatory activity of galectin-1: control of immune cell trafficking, dendritic cell physiology, and T-cell fate (2010) Methods Enzymol., 480, pp. 199-244
• Jiang, H.R., Al Rasebi, Z., Mensah-Brown, E., Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 1167-1173
• Forsman, H., Islander, U., Andréasson, E., Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis (2011) Arthritis Rheum., 63, pp. 445-454
• Dube, D.H., Bertozzi, C.R., Glycans in cancer and inflammation-potential for therapeutics and diagnostics (2005) Nat. Rev. Drug Discov., 4, pp. 477-488
• Sperandio, M., Gleissner, C.A., Ley, K., Glycosylation in immune cell trafficking (2009) Immunol. Rev., 230, pp. 97-113
• Buzás, E.I., György, B., Pásztói, M., Carbohydrate recognition systems in autoimmunity (2006) Autoimmunity, 39, pp. 691-704
• Grigorian, A., Araujo, L., Naidu, N.N., N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis (2011) J. Biol. Chem., 286, pp. 40133-40141
• Green, R.S., Stone, E.L., Tenno, M., Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis (2007) Immunity, 27, pp. 308-320
• Hiki, Y., Odani, H., Takahashi, M., Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy (2001) Kidney Int., 59, pp. 1077-1085
• Padler-Karavani, V., Yu, H., Cao, H., Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease (2008) Glycobiology, 18, pp. 818-830
• Ju, T., Cummings, R.D., Protein glycosylation: chaperone mutation in Tn syndrome (2005) Nature, 437, p. 1252
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991
• Kel, J., Oldenampsen, J., Luca, M., Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis (2007) Am. J. Pathol., 170, pp. 272-280
• Zhou, Y., Kawasaki, H., Hsu, S.C., Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1 (2010) Nat. Med., 16, pp. 1128-1133
• Jellusova, J., Wellmann, U., Amann, K., CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity (2010) J. Immunol., 184, pp. 3618-3627
• Saeland, E., Belo, A.I., Mongera, S., Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients (2011) Int. J. Cancer, , Aug 5. doi:. [Epub ahead of print]
• Bozzacco, L., Trumpfheller, C., Huang, Y., HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC (2010) Eur. J. Immunol., 40, pp. 36-46
• Klechevsky, E., Flamar, A.L., Cao, Y., Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR (2010) Blood, 116, pp. 1685-1697
• Singh, S.K., Streng-Ouwehand, I., Litjens, M., Design of neo-glycoconjugates that target the Mannose Receptor and enhance TLR independent cross-presentation and Th1 polarization (2011) Eur. J. Immunol., 41, pp. 916-925
• Burgdorf, S., Lukacs-Kornek, V., Kurtc, C., The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation (2006) J. Immunol., 176, pp. 6770-6776
• Caminischi, I., Proietto, A.I., Ahmet, F., The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement (2008) Blood, 112, pp. 3264-3273
• Sánchez-Navarro, M., Rojo, J., Targeting DC-SIGN with carbohydrate multivalent systems (2010) Drug News Perspect, 23, pp. 557-572
• Streng-Ouwehand, I., Unger, W.W.J., van Kooyk, Y., C-type lectin receptors for tumor eradication: future directions (2011) Cancers, , 3: 3169-3188
• Salatino, M., Rabinovich, G.A., Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview (2011) Methods Mol. Biol., 677, pp. 355-374
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Cedeno-Laurent, F., Opperman, M.J., Barthel, S.R., Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity (2012) J. Invest. Dermatol, 132, pp. 410-420
• Juszczynski, P., Ouyang, J., Monti, S., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 13134-13139
• Banh, A., Zhang, J., Cao, H., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res., 71, pp. 4423-4431
• Kuo, P.L., Hung, J.Y., Huang, S.K., Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway (2011) J. Immunol., 186, pp. 1521-1530
• Tang, D., Yuan, Z., Xue, X., High expression of galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2011) Int. J. Cancer., , doi:. [Epub ahead of print
• Soldati, R., Berger, E., Zenclussen, A.C., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2011) Int. J. Cancer., , doi:. [Epub ahead of print
• Dardalhon, V., Anderson, A.C., Karman, J., Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells (2010) J. Immunol., 185, pp. 1383-1392
• Demotte, N., Wieërs, G., Van Der Smissen, P., A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice (2010) Cancer Res., 70, pp. 7476-7748
• Tsuboi, S., Sutoh, M., Hatakeyama, S., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) EMBO J., 30, pp. 3173-3185
• Nicoll, G., Avril, T., Lock, K., Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms (2003) Eur. J. Immunol., 33, pp. 1642-1648
• Ohta, M., Ishida, A., Toda, M., Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9 (2010) Biochem. Biophys. Res. Commun., 402, pp. 663-669

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------